Document is current
Any future updates will be listed below
-
Authors
Wronski, Marie-Louis
Plessow, Franziska
Rogers, Madeline
Slattery, Meghan
Ehrlich, Stefan
Quintana, Daniel S.
Walle, Kjersti Mæhlum
Breithaupt, Lauren
Thomas, Jennifer J.
Holsen, Laura M.
Lawson, Elizabeth A.
Misra, Madhusmita
Eddy, Kamryn T.
-
Funding
Funding for this research was provided by:
Technische Universität Dresden
- License Information
-
More Information
Article History
Received: 11 November 2025
Accepted: 19 March 2026
First Online: 3 April 2026
Declarations
:
: Elizabeth A. Lawson receives grant support and research study drug from Tonix Pharmaceuticals and receives royalties from UpToDate. She and/or immediate family member holds/recently held stock in Thermo Fisher Scientific, Zoetis, Danaher Corporation, Intuitive Surgical, Merck, West Pharmaceutical Services, Gilead Sciences, and Illumina. Elizabeth A. Lawson and Franziska Plessow are inventors on PCTUS2025/030536 entitled, “Oxytocin-based therapeutics to improve cognitive control in individuals with attention deficit hyperactive disorder” filed on May 22, 2025. Madhusmita Misra has consulted for Regeneron and Kyss Pharmaceuticals, received study drug donation from Amgen and Tonix Pharmaceuticals, and receives honoraria from UpToDate. All other authors declare no biomedical financial interests or potential conflicts of interest.
